At the time of writing, Biolase Inc [BIOL] stock is trading at $0.15, up 1.09%. An important factor to consider is whether the stock is rising or falling in short-term value. The BIOL shares have lost -0.60% over the last week, with a monthly amount glided 6.07%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Biolase Inc [NASDAQ: BIOL] stock has seen the most recent analyst activity on June 19, 2019, when The Benchmark Company initiated its Speculative Buy rating and assigned the stock a price target of $2. Previously, Singular Research started tracking the stock with Buy rating on April 25, 2017, and set its price target to $2.50. On May 13, 2014, downgrade downgraded it’s rating to Hold and revised its price target to $2.50 on the stock. WallachBeth reiterated its Buy rating and decreased its price target to $2.75 on November 12, 2013. WallachBeth reiterated its recommendation of a Buy and reduced its price target to $4.50 on August 08, 2013. WallachBeth started tracking with a Buy rating for this stock on June 17, 2013, and assigned it a price target of $6.50. In a note dated March 18, 2013, Northland Capital reiterated an Outperform rating on this stock and boosted its target price from $6 to $7.
For the past year, the stock price of Biolase Inc fluctuated between $0.13 and $47.10. Biolase Inc [NASDAQ: BIOL] shares were valued at $0.15 at the most recent close of the market.
Analyzing the BIOL fundamentals
According to Biolase Inc [NASDAQ:BIOL], the company’s sales were 49.16M for trailing twelve months, which represents an -3.99% plunge. Gross Profit Margin for this corporation currently stands at 0.34% with Operating Profit Margin at -0.36%, Pretax Profit Margin comes in at -0.42%, and Net Profit Margin reading is -0.42%. To continue investigating profitability, this company’s Return on Assets is posted at -0.59, Equity is -3.9 and Total Capital is -1.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-69.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1432 points at the first support level, and at 0.1379 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1519, and for the 2nd resistance point, it is at 0.1553.
Ratios To Look Out For
It is important to note that Biolase Inc [NASDAQ:BIOL] has a current ratio of 1.26. On the other hand, the Quick Ratio is 0.68, and the Cash Ratio is 0.33. Considering the valuation of this stock, the price to sales ratio is 0.10.
